Who are the key players in the non24hour sleepwake disorder treatment market?

Some of the key players are Companies, Mylan NV, TEVA, Others.

BUY CHAPTERS

Global Non-24-hour Sleep-wake Disorder Treatment Market Research Report 2023

Q: How big is the non24hour sleepwake disorder treatment market?

Instead of sleeping at roughly the same time every day someone with N24 will typically find their sleep time gradually delaying by minutes to hours every day.According to QYResearchs new survey global Non24hour Sleepwake Disorder Treatment market is projected to reach US 726.1 million in 2029 increasing from US 480 million in 2022 with the CAGR of 6.1 during the period of 2023 to 2029.

Code: QYRE-Auto-26E14383

Report

June 2023

Pages:88

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Otsuka Pharma (Pharmavite)

Non-24-hour Sleep-wake Disorder Treatment Market Size

According to QYResearch’s new survey, global Non-24-hour Sleep-wake Disorder Treatment market is projected to reach US$ 726.1 million in 2029, increasing from US$ 480 million in 2022, with the CAGR of 6.1% during the period of 2023 to 2029.

Non-24-hour Sleep-wake Disorder Treatment Market

Non-24-hour sleep-wake disorder (N24) is a circadian rhythm sleep disorder in which an individual's biological clock fails to synchronize to a 24-hour day. Instead of sleeping at roughly the same time every day, someone with N24 will typically find their sleep time gradually delaying by minutes to hours every day.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Non-24-hour Sleep-wake Disorder Treatment market research.

Key companies engaged in the Non-24-hour Sleep-wake Disorder Treatment industry include Teva, Mylan, Nature’s Bounty, Otsuka Pharma (Pharmavite), Boiron, Miers Laboratories, Genexa, Homeocan and Clinigen Group, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Non-24-hour Sleep-wake Disorder Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Non-24-hour Sleep-wake Disorder Treatment market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Non-24-hour Sleep-wake Disorder Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Non-24-hour Sleep-wake Disorder Treatment Market Report

Report Metric	Details
Report Name	Non-24-hour Sleep-wake Disorder Treatment Market
Accounted market size in 2022	US$ 480 million
Forecasted market size in 2029	US$ 726.1 million
CAGR	6.1%
Base Year	2022
Forecasted years	2023 - 2029
Segment by Type	Prescription Drugs OTC
Segment by Application	Hospital Pharmacies Retail Pharmacies Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Teva, Mylan, Nature’s Bounty, Otsuka Pharma (Pharmavite), Boiron, Miers Laboratories, Genexa, Homeocan, Clinigen Group, Vanda Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Non-24-hour Sleep-wake Disorder Treatment Market market growing?

Ans: The Non-24-hour Sleep-wake Disorder Treatment Market market witnessing a CAGR of 6.1% during the forecast period 2023-2029.

What is the Non-24-hour Sleep-wake Disorder Treatment Market market size in 2029?

Ans: According to QYResearch’s new survey, global Non-24-hour Sleep-wake Disorder Treatment market is projected to reach US$ 726.1 million in 2029, increasing from US$ 480 million in 2022, with the CAGR of 6.1% during the period of 2023 to 2029.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Prescription Drugs

1.2.3 OTC

1.3 Market by Application

1.3.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Perspective (2018-2029)

2.2 Non-24-hour Sleep-wake Disorder Treatment Growth Trends by Region

2.2.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Non-24-hour Sleep-wake Disorder Treatment Historic Market Size by Region (2018-2023)

2.2.3 Non-24-hour Sleep-wake Disorder Treatment Forecasted Market Size by Region (2024-2029)

2.3 Non-24-hour Sleep-wake Disorder Treatment Market Dynamics

2.3.1 Non-24-hour Sleep-wake Disorder Treatment Industry Trends

2.3.2 Non-24-hour Sleep-wake Disorder Treatment Market Drivers

2.3.3 Non-24-hour Sleep-wake Disorder Treatment Market Challenges

2.3.4 Non-24-hour Sleep-wake Disorder Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Non-24-hour Sleep-wake Disorder Treatment Players by Revenue

3.1.1 Global Top Non-24-hour Sleep-wake Disorder Treatment Players by Revenue (2018-2023)

3.1.2 Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Players (2018-2023)

3.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Non-24-hour Sleep-wake Disorder Treatment Revenue

3.4 Global Non-24-hour Sleep-wake Disorder Treatment Market Concentration Ratio

3.4.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-24-hour Sleep-wake Disorder Treatment Revenue in 2022

3.5 Non-24-hour Sleep-wake Disorder Treatment Key Players Head office and Area Served

3.6 Key Players Non-24-hour Sleep-wake Disorder Treatment Product Solution and Service

3.7 Date of Enter into Non-24-hour Sleep-wake Disorder Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-24-hour Sleep-wake Disorder Treatment Breakdown Data by Type

4.1 Global Non-24-hour Sleep-wake Disorder Treatment Historic Market Size by Type (2018-2023)

4.2 Global Non-24-hour Sleep-wake Disorder Treatment Forecasted Market Size by Type (2024-2029)

5 Non-24-hour Sleep-wake Disorder Treatment Breakdown Data by Application

5.1 Global Non-24-hour Sleep-wake Disorder Treatment Historic Market Size by Application (2018-2023)

5.2 Global Non-24-hour Sleep-wake Disorder Treatment Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)

6.2 North America Non-24-hour Sleep-wake Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2018-2023)

6.4 North America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)

7.2 Europe Non-24-hour Sleep-wake Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2018-2023)

7.4 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)

8.2 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2018-2023)

8.4 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)

9.2 Latin America Non-24-hour Sleep-wake Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2018-2023)

9.4 Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2029)

10.2 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2018-2023)

10.4 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Teva

11.1.1 Teva Company Detail

11.1.2 Teva Business Overview

11.1.3 Teva Non-24-hour Sleep-wake Disorder Treatment Introduction

11.1.4 Teva Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)

11.1.5 Teva Recent Development

11.2 Mylan

11.2.1 Mylan Company Detail

11.2.2 Mylan Business Overview

11.2.3 Mylan Non-24-hour Sleep-wake Disorder Treatment Introduction

11.2.4 Mylan Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)

11.2.5 Mylan Recent Development

11.3 Nature’s Bounty

11.3.1 Nature’s Bounty Company Detail

11.3.2 Nature’s Bounty Business Overview

11.3.3 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Introduction

11.3.4 Nature’s Bounty Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)

11.3.5 Nature’s Bounty Recent Development

11.4 Otsuka Pharma (Pharmavite)

11.4.1 Otsuka Pharma (Pharmavite) Company Detail

11.4.2 Otsuka Pharma (Pharmavite) Business Overview

11.4.3 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Introduction

11.4.4 Otsuka Pharma (Pharmavite) Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)

11.4.5 Otsuka Pharma (Pharmavite) Recent Development

11.5 Boiron

11.5.1 Boiron Company Detail

11.5.2 Boiron Business Overview

11.5.3 Boiron Non-24-hour Sleep-wake Disorder Treatment Introduction

11.5.4 Boiron Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)

11.5.5 Boiron Recent Development

11.6 Miers Laboratories

11.6.1 Miers Laboratories Company Detail

11.6.2 Miers Laboratories Business Overview

11.6.3 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Introduction

11.6.4 Miers Laboratories Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)

11.6.5 Miers Laboratories Recent Development

11.7 Genexa

11.7.1 Genexa Company Detail

11.7.2 Genexa Business Overview

11.7.3 Genexa Non-24-hour Sleep-wake Disorder Treatment Introduction

11.7.4 Genexa Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)

11.7.5 Genexa Recent Development

11.8 Homeocan

11.8.1 Homeocan Company Detail

11.8.2 Homeocan Business Overview

11.8.3 Homeocan Non-24-hour Sleep-wake Disorder Treatment Introduction

11.8.4 Homeocan Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)

11.8.5 Homeocan Recent Development

11.9 Clinigen Group

11.9.1 Clinigen Group Company Detail

11.9.2 Clinigen Group Business Overview

11.9.3 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Introduction

11.9.4 Clinigen Group Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)

11.9.5 Clinigen Group Recent Development

11.10 Vanda Pharma

11.10.1 Vanda Pharma Company Detail

11.10.2 Vanda Pharma Business Overview

11.10.3 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Introduction

11.10.4 Vanda Pharma Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)

11.10.5 Vanda Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Otsuka Pharma (Pharmavite)

List of Tables

Table 1. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

Table 2. Key Players of Prescription Drugs

Table 3. Key Players of OTC

Table 4. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

Table 5. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Table 6. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2018-2023) & (US$ Million)

Table 7. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Region (2018-2023)

Table 8. Global Non-24-hour Sleep-wake Disorder Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 9. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Region (2024-2029)

Table 10. Non-24-hour Sleep-wake Disorder Treatment Market Trends

Table 11. Non-24-hour Sleep-wake Disorder Treatment Market Drivers

Table 12. Non-24-hour Sleep-wake Disorder Treatment Market Challenges

Table 13. Non-24-hour Sleep-wake Disorder Treatment Market Restraints

Table 14. Global Non-24-hour Sleep-wake Disorder Treatment Revenue by Players (2018-2023) & (US$ Million)

Table 15. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Players (2018-2023)

Table 16. Global Top Non-24-hour Sleep-wake Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-24-hour Sleep-wake Disorder Treatment as of 2022)

Table 17. Ranking of Global Top Non-24-hour Sleep-wake Disorder Treatment Companies by Revenue (US$ Million) in 2022

Table 18. Global 5 Largest Players Market Share by Non-24-hour Sleep-wake Disorder Treatment Revenue (CR5 and HHI) & (2018-2023)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Non-24-hour Sleep-wake Disorder Treatment Product Solution and Service

Table 21. Date of Enter into Non-24-hour Sleep-wake Disorder Treatment Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2018-2023) & (US$ Million)

Table 24. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Type (2018-2023)

Table 25. Global Non-24-hour Sleep-wake Disorder Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 26. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Type (2024-2029)

Table 27. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2018-2023) & (US$ Million)

Table 28. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Application (2018-2023)

Table 29. Global Non-24-hour Sleep-wake Disorder Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 30. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Application (2024-2029)

Table 31. North America Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 32. North America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)

Table 33. North America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2024-2029) & (US$ Million)

Table 34. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 35. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)

Table 36. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2024-2029) & (US$ Million)

Table 37. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

Table 38. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2018-2023) & (US$ Million)

Table 39. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2024-2029) & (US$ Million)

Table 40. Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 41. Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)

Table 42. Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2024-2029) & (US$ Million)

Table 43. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 44. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)

Table 45. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2024-2029) & (US$ Million)

Table 46. Teva Company Detail

Table 47. Teva Business Overview

Table 48. Teva Non-24-hour Sleep-wake Disorder Treatment Product

Table 49. Teva Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023) & (US$ Million)

Table 50. Teva Recent Development

Table 51. Mylan Company Detail

Table 52. Mylan Business Overview

Table 53. Mylan Non-24-hour Sleep-wake Disorder Treatment Product

Table 54. Mylan Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023) & (US$ Million)

Table 55. Mylan Recent Development

Table 56. Nature’s Bounty Company Detail

Table 57. Nature’s Bounty Business Overview

Table 58. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Product

Table 59. Nature’s Bounty Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023) & (US$ Million)

Table 60. Nature’s Bounty Recent Development

Table 61. Otsuka Pharma (Pharmavite) Company Detail

Table 62. Otsuka Pharma (Pharmavite) Business Overview

Table 63. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product

Table 64. Otsuka Pharma (Pharmavite) Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023) & (US$ Million)

Table 65. Otsuka Pharma (Pharmavite) Recent Development

Table 66. Boiron Company Detail

Table 67. Boiron Business Overview

Table 68. Boiron Non-24-hour Sleep-wake Disorder Treatment Product

Table 69. Boiron Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023) & (US$ Million)

Table 70. Boiron Recent Development

Table 71. Miers Laboratories Company Detail

Table 72. Miers Laboratories Business Overview

Table 73. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product

Table 74. Miers Laboratories Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023) & (US$ Million)

Table 75. Miers Laboratories Recent Development

Table 76. Genexa Company Detail

Table 77. Genexa Business Overview

Table 78. Genexa Non-24-hour Sleep-wake Disorder Treatment Product

Table 79. Genexa Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023) & (US$ Million)

Table 80. Genexa Recent Development

Table 81. Homeocan Company Detail

Table 82. Homeocan Business Overview

Table 83. Homeocan Non-24-hour Sleep-wake Disorder Treatment Product

Table 84. Homeocan Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023) & (US$ Million)

Table 85. Homeocan Recent Development

Table 86. Clinigen Group Company Detail

Table 87. Clinigen Group Business Overview

Table 88. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product

Table 89. Clinigen Group Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023) & (US$ Million)

Table 90. Clinigen Group Recent Development

Table 91. Vanda Pharma Company Detail

Table 92. Vanda Pharma Business Overview

Table 93. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product

Table 94. Vanda Pharma Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023) & (US$ Million)

Table 95. Vanda Pharma Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)

Figure 2. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Type: 2022 VS 2029

Figure 3. Prescription Drugs Features

Figure 4. OTC Features

Figure 5. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)

Figure 6. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Application: 2022 VS 2029

Figure 7. Hospital Pharmacies Case Studies

Figure 8. Retail Pharmacies Case Studies

Figure 9. Other Case Studies

Figure 10. Non-24-hour Sleep-wake Disorder Treatment Report Years Considered

Figure 11. Global Non-24-hour Sleep-wake Disorder Treatment Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 12. Global Non-24-hour Sleep-wake Disorder Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 13. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Region: 2022 VS 2029

Figure 14. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Players in 2022

Figure 15. Global Top Non-24-hour Sleep-wake Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-24-hour Sleep-wake Disorder Treatment as of 2022)

Figure 16. The Top 10 and 5 Players Market Share by Non-24-hour Sleep-wake Disorder Treatment Revenue in 2022

Figure 17. North America Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 18. North America Non-24-hour Sleep-wake Disorder Treatment Market Share by Country (2018-2029)

Figure 19. United States Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 20. Canada Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 21. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 22. Europe Non-24-hour Sleep-wake Disorder Treatment Market Share by Country (2018-2029)

Figure 23. Germany Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 24. France Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 25. U.K. Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 26. Italy Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 27. Russia Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. Nordic Countries Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Share by Region (2018-2029)

Figure 31. China Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Japan Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. South Korea Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. India Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 36. Australia Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 37. Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 38. Latin America Non-24-hour Sleep-wake Disorder Treatment Market Share by Country (2018-2029)

Figure 39. Mexico Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 40. Brazil Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 41. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Share by Country (2018-2029)

Figure 43. Turkey Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. Saudi Arabia Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Teva Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)

Figure 46. Mylan Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)

Figure 47. Nature’s Bounty Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)

Figure 48. Otsuka Pharma (Pharmavite) Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)

Figure 49. Boiron Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)

Figure 50. Miers Laboratories Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)

Figure 51. Genexa Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)

Figure 52. Homeocan Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)

Figure 53. Clinigen Group Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)

Figure 54. Vanda Pharma Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Non-24-hour Sleep-wake Disorder Treatment Market Research Report 2023

Published Date: June 2023

Report Code: QYRE-Auto-26E14383

Global Non-24-hour Sleep-wake Disorder Treatment Market Research Report 2023

FEATURED COMPANIES

Non-24-hour Sleep-wake Disorder Treatment Market Size

Non-24-hour Sleep-wake Disorder Treatment Market

Report Scope

Scope of Non-24-hour Sleep-wake Disorder Treatment Market Report

FAQ for this report

How fast is Non-24-hour Sleep-wake Disorder Treatment Market market growing?

What is the Non-24-hour Sleep-wake Disorder Treatment Market market size in 2029?

FEATURED COMPANIES

RELATED REPORTS